| Income Statement |
| Total Revenue | 230.62M |
|
| Revenues (USD) | 230.62M |
| Cost of Revenue | 155.49M |
| Gross Profit | 75.13M |
| Operating Expenses | 47.90M |
| Research and Development Expense | 12.09M |
| Selling, General and Administrative Expense | 35.81M |
| Operating Income | 27.23M |
| Interest Expense | 2.34M |
| Income Tax Expense | -755.00K |
| Net Income | 25.54M |
| Net Income Common Stock | 25.54M |
| Net Income Common Stock (USD) | 25.54M |
| Consolidated Income | 25.54M |
| Earnings per Basic Share | 0.71 |
| Earnings per Basic Share (USD) | 0.71 |
| Earnings per Diluted Share | 0.67 |
| Earning Before Interest & Taxes (EBIT) | 27.12M |
| Earning Before Interest & Taxes (USD) | 27.12M |
| Weighted Average Shares | 35.69M |
| Balance Sheet |
| Cash and Equivalents | 11.87M |
| Cash and Equivalents (USD) | 11.87M |
| Trade and Non-Trade Receivables | 217.02M |
| Current Assets | 468.63M |
| Property, Plant & Equipment Net | 148.11M |
| Total Assets | 747.14M |
| Debt Current | 5.99M |
| Total Debt | 379.11M |
| Current Liabilities | 157.71M |
| Debt Non-Current | 373.12M |
| Total Liabilities | 585.44M |
| Accumulated Other Comprehensive Income | -5.44M |
| Shareholders Equity | 161.70M |
| Shareholders Equity (USD) | 161.70M |
| Assets Non-Current | 278.52M |
| Total Debt (USD) | 379.11M |
| Deferred Revenue | 29.67M |
| Goodwill and Intangible Assets | 116.67M |
| Inventory | 211.95M |
| Liabilities Non-Current | 427.73M |
| Trade and Non-Trade Payables | 55.87M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 7.36M |
| Net Cash Flow from Financing | -5.50M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.31M |
| Capital Expenditure | -11.16M |
| Issuance (Purchase) of Equity Shares | -5.44M |
| Net Cash Flow from Investing | -11.16M |
| Net Cash Flow from Operations | 10.61M |
| Effect of Exchange Rate Changes on Cash | -258.00K |
| Share Based Compensation | 2.56M |